|
| |
| | | 00534 | | 03.12.1986 | | GlaxoSmithKline AG | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Engerix-B 20 | Injektionssuspension | Injection suspension (Hepatitidis b viri Antigenum Adnr 20 µg/ml) | J07BC01 | | | 02 | Engerix B 20 | | (Vaccinum Hepatitidis b (Adnr) Hbsag 20 mcg) | Codice | |
|
|
|
